RCUS vs. SCHZ

Last updated Apr 2, 2026

Compare and contrast key facts about Arcus Biosciences, Inc. (RCUS) and Schwab U.S. Aggregate Bond ETF (SCHZ).

SCHZ is a passively managed fund by Charles Schwab that tracks the performance of the Bloomberg US Aggregate Bond Index. It was launched on Jul 14, 2011.

Performance

RCUS vs. SCHZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcus Biosciences, Inc. (RCUS) and Schwab U.S. Aggregate Bond ETF (SCHZ). The values are adjusted to include any dividend payments, if applicable.

RCUS vs. SCHZ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
RCUS Arcus Biosciences, Inc.	-8.35%	60.04%	-22.04%	-7.64%	-48.90%	55.89%	157.03%	-6.22%	-36.65%
SCHZ Schwab U.S. Aggregate Bond ETF	0.13%	7.24%	1.26%	5.60%	-13.17%	-1.72%	7.46%	8.65%	1.68%

Returns By Period

In the year-to-date period, RCUS achieves a -8.35% return, which is significantly lower than SCHZ's 0.13% return.

RCUS

• 1D: 1.11%
• 1M: -8.77%
• YTD: -8.35%
• 6M: 62.02%
• 1Y: 183.27%
• 3Y*: 6.19%
• 5Y*: -5.40%
• 10Y*: —

SCHZ

• 1D: 0.08%
• 1M: -1.32%
• YTD: 0.13%
• 6M: 0.79%
• 1Y: 4.07%
• 3Y*: 3.59%
• 5Y*: 0.21%
• 10Y*: 1.62%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RCUS vs. SCHZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCUS

RCUS Risk / Return Rank: 93
RCUS Sharpe Ratio Rank: 95
RCUS Sortino Ratio Rank: 91
RCUS Omega Ratio Rank: 89
RCUS Calmar Ratio Rank: 96
RCUS Martin Ratio Rank: 95

SCHZ

SCHZ Risk / Return Rank: 52
SCHZ Sharpe Ratio Rank: 51
SCHZ Sortino Ratio Rank: 48
SCHZ Omega Ratio Rank: 41
SCHZ Calmar Ratio Rank: 68
SCHZ Martin Ratio Rank: 51

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCUS vs. SCHZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcus Biosciences, Inc. (RCUS) and Schwab U.S. Aggregate Bond ETF (SCHZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RCUS	SCHZ	Difference
Sharpe ratio Return per unit of total volatility	2.82	0.96	+1.86
Sortino ratio Return per unit of downside risk	3.07	1.36	+1.71
Omega ratio Gain probability vs. loss probability	1.39	1.17	+0.22
Calmar ratio Return relative to maximum drawdown	6.42	1.79	+4.62
Martin ratio Return relative to average drawdown	16.46	5.11	+11.35
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RCUS vs. SCHZ - Sharpe Ratio Comparison

The current RCUS Sharpe Ratio is 2.82, which is higher than the SCHZ Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of RCUS and SCHZ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RCUS	SCHZ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.82	0.96	+1.86
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.08	0.04	-0.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.30	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.04	0.44	-0.40

Correlation

The correlation between RCUS and SCHZ is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

RCUS vs. SCHZ - Dividend Comparison

RCUS has not paid dividends to shareholders, while SCHZ's dividend yield for the trailing twelve months is around 4.10%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
RCUS Arcus Biosciences, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SCHZ Schwab U.S. Aggregate Bond ETF	4.10%	4.05%	3.96%	3.28%	2.63%	2.16%	2.43%	2.79%	2.56%	2.40%	2.24%	2.11%

Drawdowns

RCUS vs. SCHZ - Drawdown Comparison

The maximum RCUS drawdown since its inception was -85.83%, which is greater than SCHZ's maximum drawdown of -18.74%. Use the drawdown chart below to compare losses from any high point for RCUS and SCHZ.

Drawdown Indicators

	RCUS	SCHZ	Difference
Max Drawdown Largest peak-to-trough decline	-85.83%	-18.74%	-67.09%
Max Drawdown (1Y) Largest decline over 1 year	-27.78%	-2.51%	-25.27%
Max Drawdown (5Y) Largest decline over 5 years	-85.83%	-18.01%	-67.82%
Max Drawdown (10Y) Largest decline over 10 years	—	-18.74%	—
Current Drawdown Current decline from peak	-54.94%	-2.63%	-52.31%
Average Drawdown Average peak-to-trough decline	-46.47%	-3.70%	-42.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	10.83%	0.88%	+9.95%

Volatility

RCUS vs. SCHZ - Volatility Comparison

Arcus Biosciences, Inc. (RCUS) has a higher volatility of 16.51% compared to Schwab U.S. Aggregate Bond ETF (SCHZ) at 1.66%. This indicates that RCUS's price experiences larger fluctuations and is considered to be riskier than SCHZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RCUS	SCHZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.51%	1.66%	+14.85%
Volatility (6M) Calculated over the trailing 6-month period	49.26%	2.50%	+46.76%
Volatility (1Y) Calculated over the trailing 1-year period	65.43%	4.29%	+61.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	67.23%	6.06%	+61.17%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.75%	5.40%	+71.35%